Format
Sort by
Items per page

Send to

Choose Destination

Best matches for Mäkelä O[au]:

Hair follicle dermal condensation forms via Fgf20 primed cell cycle exit, cell motility, and aggregation. Biggs LC et al. Elife. (2018)

Inherited immunoglobulin idiotypes of the mouse. Mäkelä O et al. Immunol Rev. (1977)

[Immunological tolerance and autoimmunity]. Mäkelä O et al. Nord Med. (1969)

Search results

Items: 1 to 50 of 225

1.

Hair follicle dermal condensation forms via Fgf20 primed cell cycle exit, cell motility, and aggregation.

Biggs LC, Mäkelä OJ, Myllymäki SM, Das Roy R, Närhi K, Pispa J, Mustonen T, Mikkola ML.

Elife. 2018 Jul 31;7. pii: e36468. doi: 10.7554/eLife.36468.

2.

Effect of insemination volume on uterine contractions and inflammatory response and on elimination of semen in the mare uterus-scintigraphic and ultrasonographic studies.

Sinnemaa L, Järvimaa T, Lehmonen N, Mäkelä O, Reilas T, Sankari S, Katila T.

J Vet Med A Physiol Pathol Clin Med. 2005 Nov;52(9):466-71.

PMID:
16268958
4.

Effect of radiosynovectomy with holmium-166 ferric hydroxide macroaggregate on adult equine cartilage.

Mäkelä OT, Lammi MJ, Uusitalo H, Viitanen M, Hyttinen MM, Jurvelin JS, Vuorio E, Helminen HJ, Tulamo RM.

J Rheumatol. 2004 Feb;31(2):321-8.

PMID:
14760804
5.

Increased pulmonary transit times in asymptomatic dogs with mitral regurgitation.

Lord P, Eriksson A, Häggström J, Järvinen AK, Kvart C, Hansson K, Maripuu E, Mäkelä O.

J Vet Intern Med. 2003 Nov-Dec;17(6):824-9.

6.

Radiation synovectomy with holmium-166 ferric hydroxide macroaggregate in equine metacarpophalangeal and metatarsophalangeal joints.

Mäkelä O, Sukura A, Penttilä P, Hiltunen J, Tulamo RM.

Vet Surg. 2003 Jul-Aug;32(4):402-9.

PMID:
12866004
7.

Analysis of lapine cartilage matrix after radiosynovectomy with holmium-166 ferric hydroxide macroaggregate.

Mäkelä OT, Lammi MJ, Uusitalo H, Hyttinen MM, Vuorio E, Helminen HJ, Tulamo RM.

Ann Rheum Dis. 2003 Jan;62(1):43-9.

8.

Experimental radiation synovectomy in rabbit knee with holmium-166 ferric hydroxide macroaggregate.

Mäkelä O, Penttilä P, Kolehmainen E, Sukura A, Sankari S, Tulamo RM.

Nucl Med Biol. 2002 Jul;29(5):593-8.

PMID:
12088730
9.
10.

Synovial fluid studies in navicular disease.

Viitanen M, Bird J, Makela O, Schramme M, Smith R, Tulamo RM, May S.

Res Vet Sci. 2001 Dec;71(3):201-6.

PMID:
11798295
11.

Transport of spermatozoa in the reproductive tracts of mares.

Katila T, Sankari S, Mäkelä O.

J Reprod Fertil Suppl. 2000;(56):571-8.

PMID:
20681171
12.

Allotype-associated differences in concentrations of human IgA2.

Mattila PS, Seppälä IJ, Sarvas H, Mäkelä O.

Scand J Immunol. 1998 Feb;47(2):106-9.

13.

Intrauterine fluid accumulation in oestrous mares.

Reilas T, Katila T, Mäkelä O, Huhtinen M, Koskinen E.

Acta Vet Scand. 1997;38(1):69-78.

PMID:
9129348
14.

Extensive allelic sequence variation in the J region of the human immunoglobulin heavy chain gene locus.

Mattila PS, Schugk J, Wu H, Mäkelä O.

Eur J Immunol. 1995 Sep;25(9):2578-82.

PMID:
7589129
15.

A 64,X,i(Xq) karyotype in a standardbred filly.

Mäkelä O, Gustavsson I, Hollmén T.

Equine Vet J. 1994 May;26(3):251-4. No abstract available.

PMID:
8542850
16.

V-region-mediated binding of human Ig by protein A.

Ibrahim S, Seppälä I, Mäkelä O.

J Immunol. 1993 Oct 1;151(7):3597-603.

PMID:
8376795
17.

Low concentrations of Gm allotypic subsets G3 mg and G1 mf in homozygotes and heterozygotes.

Seppälä IJ, Sarvas H, Mäkelä O.

J Immunol. 1993 Sep 1;151(5):2529-37.

PMID:
8360475
18.

Proportion of protein A bindable molecules in human IgM and IgA antibodies to seven antigens.

Ibrahim S, Seppälä IJ, Sarvas H, Mäkelä O.

Microb Pathog. 1993 Sep;15(3):159-68.

PMID:
8271916
19.

Half-life of the maternal IgG1 allotype in infants.

Sarvas H, Seppälä I, Kurikka S, Siegberg R, Mäkelä O.

J Clin Immunol. 1993 Mar;13(2):145-51.

PMID:
8320311
20.

The alternative binding site for protein A in the Fab fragment of immunoglobulins.

Ibrahim S, Kaartinen M, Seppälä I, Matoso-Ferreira A, Mäkelä O.

Scand J Immunol. 1993 Feb;37(2):257-64.

PMID:
8434237
21.

The same few V genes account for a majority of oxazolone antibodies in most mouse strains.

Solin ML, Kaartinen M, Mäkelä O.

Mol Immunol. 1992 Nov;29(11):1357-62.

PMID:
1406722
22.

Maternal antibodies partly inhibit an active antibody response to routine tetanus toxoid immunization in infants.

Sarvas H, Kurikka S, Seppälä IJ, Mäkelä PH, Mäkelä O.

J Infect Dis. 1992 May;165(5):977-9. No abstract available.

PMID:
1569355
23.

Quantitation of human IgG subclass antibodies to Haemophilus influenzae type b capsular polysaccharide. Results of an international collaborative study using enzyme immunoassay methodology.

Herrmann DJ, Hamilton RG, Barington T, Frasch CE, Arakere G, Mäkelä O, Mitchell LA, Nagel J, Rijkers GT, Zegers B, et al.

J Immunol Methods. 1992 Apr 8;148(1-2):101-14.

PMID:
1564320
24.

V genes of oxazolone antibodies in 10 strains of mice.

Kaartinen M, Solin ML, Mäkelä O.

Eur J Immunol. 1991 Nov;21(11):2863-9.

PMID:
1936125
25.

Gm allotypes influence the production of IgG3 but the effect is age-dependent.

Rautonen N, Sarvas H, Julkunen I, Pyhälä R, Mäkelä O.

Hum Immunol. 1991 Sep;32(1):72-7.

PMID:
1774195
26.

Allotype-associated differences in concentrations of human IgG subclasses.

Sarvas H, Rautonen N, Mäkelä O.

J Clin Immunol. 1991 Jan;11(1):39-45.

PMID:
2022720
27.

Mouse Ig coded by VH families S107 or J606 bind to protein A.

Seppälä I, Kaartinen M, Ibrahim S, Mäkelä O.

J Immunol. 1990 Nov 1;145(9):2989-93.

PMID:
2120342
28.

Effect of Gm allotypes on IgG2 antibody responses and IgG2 concentrations in children and adults.

Sarvas H, Rautonen N, Käyhty H, Kallio M, Mäkelä O.

Int Immunol. 1990;2(4):317-22.

PMID:
2278990
30.

'Allelic' forms of immunoglobulin V genes in different strains of mice.

Kaartinen M, Solin ML, Mäkelä O.

EMBO J. 1989 Jun;8(6):1743-8.

31.

One allele [G2m(n)] of the human IgG2 locus is more productive than the other.

Rautonen N, Sarvas H, Mäkelä O.

Eur J Immunol. 1989 May;19(5):817-22.

PMID:
2737238
32.

Recent primary toxoplasma infection indicated by a low avidity of specific IgG.

Hedman K, Lappalainen M, Seppäiä I, Mäkelä O.

J Infect Dis. 1989 Apr;159(4):736-40.

PMID:
2926163
33.

Antibody responses to hapten in thymectomized mice: extraordinarily pronounced deficiency in IgG1 production.

Seppälä IJ, Hurme M, Mäkelä O.

Scand J Immunol. 1989 Apr;29(4):469-75.

PMID:
2655066
34.

IgG subclasses of pneumococcal antibodies--effect of allotype G2m(n).

Sarvas H, Rautonen N, Sipinen S, Mäkelä O.

Scand J Immunol. 1989 Feb;29(2):229-37.

PMID:
2922573
35.

Determination of homozygosity or heterozygosity for the G2m(n) allotype by a monoclonal, precipitating antibody.

Rautonen N, Seppälä I, Hallberg T, Grubb R, Mäkelä O.

Exp Clin Immunogenet. 1989;6(1):31-8.

PMID:
2517026
36.

Isotype distribution and bactericidal activity of antibodies after immunization with Haemophilus influenzae type b vaccines at 18-24 months of age.

Käyhty H, Mäkelä O, Eskola J, Saarinen L, Seppälä I.

J Infect Dis. 1988 Nov;158(5):973-82.

PMID:
3053931
37.

Human antibody responses to two conjugate vaccines of Haemophilus influenzae type B saccharides and diphtheria toxin.

Seppälä I, Sarvas H, Mäkelä O, Mattila P, Eskola J, Käyhty H.

Scand J Immunol. 1988 Oct;28(4):471-9.

PMID:
3264084
38.

Genetic control of early antibody responses.

Mäkelä O, Kaartinen M.

Immunol Rev. 1988 Oct;105:85-96. Review.

PMID:
3058581
40.

V genes of the primary antibody response of C57BL/10 mice to the hapten phenyloxazolone.

Kaartinen M, Pelkonen E, Even J, Mäkelä O.

Eur J Immunol. 1988 Jul;18(7):1095-100.

PMID:
3136024
42.

Proportions of immunoglobulin isotypes in paralytic poliomyelitis and after vaccination.

Julkunen I, Ukkonen P, Stenvik M, Hovi T, Renkonen L, Mäkelä O.

J Clin Immunol. 1987 Jul;7(4):319-26.

PMID:
3611298
44.

Salivary and serum antibodies in patients with Yersinia enterocolitica infection.

Grönblad EA, Mäkelä O.

Microb Pathog. 1986 Dec;1(6):565-71.

PMID:
3508499
45.

Proportions of IgG subclasses in antibodies formed during vaccination with hepatitis B surface antigen.

Mattila PS, Pelkonen J, Mäkelä O.

Scand J Immunol. 1986 Dec;24(6):699-704.

PMID:
2948273
46.

Isotype concentrations of human antibodies to group A meningococcal polysaccharide.

Rautonen N, Pelkonen J, Sipinen S, Käyhty H, Mäkelä O.

J Immunol. 1986 Oct 15;137(8):2670-5.

PMID:
3093581
47.

Evaluation of CA 19-9 as a serum tumour marker in pancreatic cancer.

Haglund C, Roberts PJ, Kuusela P, Scheinin TM, Mäkelä O, Jalanko H.

Br J Cancer. 1986 Feb;53(2):197-202.

48.

Quantitative representation of two germ-line V genes in the early antibody response to 2-phenyloxazolone.

Pelkonen J, Kaartinen M, Mäkelä O.

Eur J Immunol. 1986 Jan;16(1):106-9.

PMID:
3948906
49.

Several V genes participate in the early phenyloxazolone response in various combinations.

Kaartinen M, Pelkonen J, Mäkelä O.

Eur J Immunol. 1986 Jan;16(1):98-105.

PMID:
3081356
50.

Reading of D genes in variable frames as a source of antibody diversity.

Kaartinen M, Mäkelä O.

Immunol Today. 1985 Nov;6(11):324-7. doi: 10.1016/0167-5699(85)90127-6. No abstract available.

PMID:
25291001

Supplemental Content

Loading ...
Support Center